共 50 条
- [21] USTEKINUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE UNISTAR STUDY LONG-TERM EXTENSIONGASTROENTEROLOGY, 2023, 164 (06) : S1185 - S1185Rosh, Joel R.Turner, DanCohen, Stanley A.Griffiths, Anne M.Hyams, Jeffrey S.Kierkus, JaroslawAdedokun, Omoniyi J.Strauss, RichardKim, LilianneVolger, Sheri
- [22] Real World Ustekinumab Use in Pediatric Patients With Crohn's DiseaseAMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10) : S1056 - S1056Ritter, Timothy E.Sarles, Harry E.Whitney, Annette E.Kim-Romo, Dawn N.Van Anglen, Lucinda J.
- [23] Patients with Crohn's disease treated with ustekinumab vs. vedolizumab in real-world settingsJOURNAL OF CROHNS & COLITIS, 2020, 14 : S630 - S630Chiorean, M.Jiang, J.Candela, N.Chen, G.Romdhani, H.Latremouille-Viau, D.Shi, S.Bungay, R.Fan, T.
- [24] Effectiveness and Safety of ustekinumab in the Treatment of Penetrating Crohn's Disease: A Prospective Real-World StudyJOURNAL OF CROHNS & COLITIS, 2025, 19 : i1413 - i1414Wu, Y.Huang, Z.Deng, X.Chao, K.Wu, Yan-HuiHuang, Zhao-PengDeng, Xiao-XiaLin, Min-ZhiHuang, Zi-ChengGao, XiangChao, Kang
- [25] Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidenceDIGESTIVE AND LIVER DISEASE, 2019, 51 (09) : 1232 - 1240Engel, TalYung, Diana E.Ma, ChristopherPariente, BenjaminWils, PaulineEliakim, RamiUngar, BellaBen-Horin, ShomronKopylov, Uri
- [26] Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN StudyINFLAMMATORY BOWEL DISEASES, 2022, 28 (11) : 1725 - 1736Chaparro, MariaBaston-Rey, IriaFernandez-Salgado, EstelaGonzalez Garcia, JavierRamos, LauraDiz-Lois Palomares, Maria TeresaArguelles-Arias, FedericoIglesias Flores, EvaCabello, MercedesRubio Iturria, SaioaNunez Ortiz, AndreaCharro, MaraGinard, DanielDuenas Sadornil, CarmenMerino Ochoa, OlgaBusquets, DavidIyo, EduardoGutierrez Casbas, AnaRamirez de la Piscina, PatriciaMaia Bosca-Watts, MartaArroyo, MaiteJose Garcia, MariaHinojosa, EstherGordillo, JordiMartinez Montiel, PilarVelayos Jimenez, BenitoQuilez Ivorra, CristinaVazquez Moron, Juan MariaMaria Huguet, JoseGonzalez-Lama, YagoMunagorri Santos, Ana IsabelManuel Amo, VictorDolores Martin-Arranz, MariaBermejo, FernandoMartinez Cadilla, JesusRubin de Celix, CristinaFradejas Salazar, PaolaLopez San Roman, AntonioJimenez, NuriaGarcia Lopez, SantiagoFiguerola, AnnaJimenez, ItxasoMartinez Cerezo, Francisco JoseTaxonera, CarlosVarela, Pilarde Francisco, RuthMonfort, DavidMolina Arriero, GemaHernandez Camba, AlejandroJavier Garcia-Alonso, Francisco
- [27] COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED WITH USTEKINUMAB AS TREATMENT FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE IN THE UNITED STATESVALUE IN HEALTH, 2017, 20 (05) : A183 - A183Zouraq, Azzabi, IWilson, M.Hather, G.Curtis, R.Luo, M.Khalid, J. M.Minda, K.
- [28] Effectiveness comparison between ustekinumab and infliximab for Crohn's disease complicated with intestinal stenosis: a multicenter real-world studyTHERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17He, XidongWang, YufangSun, JingyaoLi, YueqinRuan, GechongLi, YueZheng, WeiyangZhang, XiaolanZhan, RongrongDing, XueliLiu, AilingChen, YijiaHu, YiqunYang, HongQian, Jiaming
- [29] Real-world effectiveness and safety of ustekinumab for the treatment of refractory Crohn's disease: The Scottish ustekinumab cohortJOURNAL OF CROHNS & COLITIS, 2020, 14 : S484 - S484Plevris, N.Robertson, A.Fulforth, J.Hall, R.Campbell, I.Kane, C.Veryan, J.Lam, W.Saunders, J.Jenkinson, P.Chuah, C.Kelly, C.Watts, D.Gaya, D.Macdonald, J.Jafferbhoy, H.Seenan, J. P.Mowat, C.Sutherland, D.Naismith, G.Bain, G.Arnott, I.Jones, G.Lees, C.
- [30] EFFICACY, SAFETY, TOLERABILITY OF USTEKINUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM UNISTAR, A PHASE 1 STUDYGASTROENTEROLOGY, 2020, 158 (06) : S235 - S236Rosh, Joel R.Turner, DanGriffiths, Anne M.Jacobstein, DouglasAdedokun, Omoniyi J.Padgett, LakshmiTerry, Natalie A.O'Brien, Christopher D.Hyams, Jeffrey S.